Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:57
|
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 50 条
  • [1] Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene
    Fink, M
    Weinhausel, A
    Niederle, B
    Haas, OA
    INTERNATIONAL JOURNAL OF CANCER, 1996, 69 (04) : 312 - 316
  • [2] Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma
    Eng, C
    Thomas, GA
    Neuberg, DS
    Mulligan, LM
    Healey, CS
    Houghton, C
    Frilling, A
    Raue, F
    Williams, ED
    Ponder, BAJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12): : 4310 - 4313
  • [3] Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma
    Marsh, DJ
    Learoyd, DL
    Andrew, SD
    Krishnan, L
    Pojer, R
    Richardson, AL
    Delbridge, L
    Eng, C
    Robinson, BG
    CLINICAL ENDOCRINOLOGY, 1996, 44 (03) : 249 - 257
  • [4] Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
    Wohllk, N
    Cote, GJ
    Bugalho, MMJ
    Ordonez, N
    Evans, DB
    Goepfert, H
    Khorana, S
    Schultz, P
    Richards, CS
    Gagel, RF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10): : 3740 - 3745
  • [5] Occurrence of sporadic medullary thyroid carcinoma in Graves' disease in association with a RET proto-oncogene mutation
    Donckier, Julian E.
    Fervaille, Caroline
    Bertrand, Claude
    ACTA CLINICA BELGICA, 2022, 77 (03) : 596 - 599
  • [6] Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma
    Eng, C
    Mulligan, LM
    Healey, CS
    Houghton, C
    Frilling, A
    Raue, F
    Thomas, GA
    Ponder, BAJ
    CANCER RESEARCH, 1996, 56 (09) : 2167 - 2170
  • [7] A novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma
    Alemi, M
    Lucas, SD
    Sallstrom, JF
    Akerstrom, G
    Wilander, E
    ANTICANCER RESEARCH, 1996, 16 (5A) : 2619 - 2622
  • [8] Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma
    Gemignani, Federica
    Romei, Cristina
    Ciampi, Raffaele
    Corrado, Alda
    Melaiu, Ombretta
    Figlioli, Gisella
    Bonotti, Alessandra
    Foddis, Rudy
    Cristaudo, Alfonso
    Pellegrini, Giovanni
    Vivaldi, Agnese
    Cipollini, Monica
    Landi, Stefano
    Elisei, Rossella
    THYROID, 2020, 30 (11) : 1579 - 1588
  • [9] Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC
    Yutaka Kitamura
    Paul J Goodfellow
    Kazuo Shimizu
    Mistuji Nagahama
    Kunihiko Ito
    Wataru Kitagawa
    Hiroki Akasu
    Hiroshi Takami
    Shigeo Tanaka
    Samuel A Wells Jr
    Oncogene, 1997, 14 : 3103 - 3106
  • [10] Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): Mutation analysis in Japanese patients with MTC
    Kitamura, Y
    Goodfellow, PJ
    Shimizu, K
    Nagahama, M
    Ito, K
    Kitagawa, W
    Akasu, H
    Takami, H
    Tanaka, S
    Wells, SA
    ONCOGENE, 1997, 14 (25) : 3103 - 3106